Please Login to read the full article.
Clinica
Medtech industry raises concern over US FDA guidance on benefit-risk assessment
22 November 2011
Vibha Sharma
Please Login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- US FDA may be calling for increasingly demanding study device designs, signals draft guidance
- US FDA device reviewers to use new worksheet from 1 May to capture benefit-risk determinations
- US Supreme Court hears dosing-test patent case that could decide future of personalised medicine
- Medtronic ASPIREs to artificial pancreas – trial results bring it a step closer
Other Informa News
EVENTS
